BCM
ABBV icon

Basso Capital Management’s AbbVie ABBV Stock Holding History

Basso Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$103K Hold
472
– – 0.06% 78
2025
Q4 		$108K Buy
+472
New +$108K 0.06% 70
2023
Q2 		– Sell
-6,100
Closed -$972K – 90
2023
Q1 		$972K Hold
6,100
– – 0.94% 29
2022
Q4 		$986K Buy
+6,100
New +$935K 1.06% 28

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Basso Capital Management's ABBV Position: Q1 2026 in Review

Basso Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 472 shares worth $103K. The position accounts for 0.06% of the portfolio, ranked #78.

Basso Capital Management first reported a position in ABBV in Q4 2022 and has held it in 4 quarters since. The position peaked at $986K in Q4 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Basso Capital Management held 472 shares of AbbVie worth $103K as of Q1 2026.
  • Basso Capital Management left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.06% of Basso Capital Management's portfolio in Q1 2026, its #78 holding.
  • Basso Capital Management first reported a position in AbbVie in Q4 2022 and has held it in 4 quarters since.
  • Basso Capital Management's AbbVie position peaked at $986K in Q4 2022.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Basso Capital Management's 13F filing for Q1 2026, filed 15 May 2026.